Showing results (1-10 of 89) with videos related to
Sort By:
Pageof 9
Cancer Control : Journal of the Moffitt Cancer Center|November 15, 2016
A Single-Institution Study of Demographics and Outcomes of Adult Patients With Multiple CancersThanh P Ho, Nathan R Foster, Aminah JatoiJournal of Thoracic Disease|January 10, 2017
Survival analyses in lung cancerKari Chansky, Dragan Subotic, Nathan R Foster, et al.Journal of Cachexia, Sarcopenia and Muscle|March 14, 2014
Patients' rationale for declining participation in a cancer-associated weight loss studyTammy Wanger, Nathan R Foster, Phuong L Nguyen, et al.Cancer Biology & Therapy|November 30, 2012
Prognostic impact of Beclin 1, p62/sequestosome 1 and LC3 protein expression in colon carcinomas from patients receiving 5-fluorouracil as adjuvant chemotherapyJae Myung Park, Shengbing Huang, Tsung-Teh Wu, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2010
Obesity is an independent prognostic variable in colon cancer survivorsFrank A Sinicrope, Nathan R Foster, Daniel J Sargent, et al.Journal of Gastrointestinal Cancer|October 17, 2022
Incidence of Brain Metastasis as First Event in Patients with Esophageal Carcinoma: a Report from Three Prospective Alliance Clinical TrialsRon S Smith, Nathan R Foster, Aminah Jatoi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 2010
Comparison of error rates in single-arm versus randomized phase II cancer clinical trialsHui Tang, Nathan R Foster, Axel Grothey, et al.Clinical Medicine. Oncology|September 6, 2011
Pemetrexed, Carboplatin, and Concomitant Radiation followed by Surgery for Locally Advanced Esophageal Cancer: Results of a Planned Interim Toxicity Analysis of North Central Cancer Treatment Group Study N044ERajini Katipamula, Aminah Jatoi, Nathan R Foster, et al.Cancer Control : Journal of the Moffitt Cancer Center|December 19, 2015
Should Vital Signs Be Routinely Obtained Prior to Intravenous Chemotherapy? Results From a 2-Center StudySmitha Menon, Nathan R Foster, Sherry Looker, et al.Investigational New Drugs|May 9, 2015
Phase II trial of gemcitabine and tanespimycin (17AAG) in metastatic pancreatic cancer: a Mayo Clinic Phase II Consortium studyKatrina S Pedersen, George P Kim, Nathan R Foster, et al.Pageof 9